Comparison of Programmable and Non-programmable CSF Shunts Among Adult Hydrocephalus Patients With Different Etiologies

Sponsor
Chang Gung Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05534659
Collaborator
Ministry of Science and Technology, Taiwan (Other)
325
66.9

Study Details

Study Description

Brief Summary

Programmable valve (PV) has been shown as a solution to the high revision rate in pediatric hydrocephalus patients, but it remains controversial among adults. This study is to compare the overall revision rate, revision cause, and revision-free survival between PV and non-programmable valve (NPV) in adult patients with different hydrocephalus etiologies.

Condition or Disease Intervention/Treatment Phase
  • Device: Programmable valve
  • Device: Non-programmable valve

Detailed Description

Relatively high revision rates up to 32% of CSF shunting operations remained an unsolved problem for neurosurgeons. The cause of revisions were diverse, including overdrainage/underdrainage, shunting system obstruction, infection or technical skill related. Programmable valve (PV) has been shown as a solution to the high revision rate in pediatric hydrocephalus patients, but it remains controversial among adults. This study is to compare the overall revision rate, revision cause, and revision-free survival between PV and non-programmable valve (NPV) in adult patients with different hydrocephalus etiologies.

The investigators reviewed the chart of all patients with hydrocephalus receiving index ventricular CSF shunt operations conducted at a single institution in northern Taiwan from January 2017 to December 2017. Patients included in the study were followed up for at least five years. Statistical tests including independent t-test, Chi-square test and Fisher's exact test were used for comparative analysis, and Kaplan-Meier curve using log-rank test was performed to compare the revision-free survival between the PV and NPV groups

Study Design

Study Type:
Observational
Actual Enrollment :
325 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Comparison of Benefit and Survival for Different Etiologies of Adult Patients With Hydrocephalus Between Programmable Cerebrospinal Fluid Ventricular Shunt and Non-programmable Cerebrospinal Fluid Ventricular Shunt
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Jul 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Programmable valve(PV) group

Adult patients with hydrocephalus who received programmable ventricular CSF shunts operation.

Device: Programmable valve
Programmable valve used in the study included Medtronic Strata, B-Braun ProGav, Codman Certas.

Non-programmable valve(NPV) group

Adult patients with hydrocephalus who received non-programmable ventricular CSF shunts operation.

Device: Non-programmable valve
Non-programmable valve used in the study was Medtronic CSF-flow control valve.

Outcome Measures

Primary Outcome Measures

  1. Initial Shunt revision rate [since the time of index operation until the initial revision or 2022/07/31]

    the ratio of the total number of patients with at least one revision to the total number of patients included in this study

  2. Total Shunt revision rate [since the time of index operation until the initial revision or 2022/07/31]

    the ratio of the total number of revisions to the total number of ventricular CSF shunt operations

  3. The cause of shunt revision [since the time of index operation until the initial revision or 2022/07/31]

    the cause of the shunt malfunction warranting revision operation

  4. Type of the revision operation [since the time of index operation until the initial revision or 2022/07/31]

    the detailed description of the revision operation

  5. Revision-free survival [since the time of index operation until the initial revision or 2022/07/31]

    the interval between index operation and the initial revision

Secondary Outcome Measures

  1. Shunt revision-free survival among different hydrocephalus etiologies [since the time of index operation until the initial revision or 2022/07/31]

    the individual interval between index operation and the initial revision among different hydrocephalus etiologies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • received shunting operations at Chang Gung Medical Foundation, Linkou Branch from 2017/01/01~2017/12/31
Exclusion Criteria:
  • Patients who received index ventricular CSF shunt at other hospitals,

  • Patients who received index ventricular CSF shunt before January 1st 2017,

  • Patients who were younger than 18

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Chang Gung Memorial Hospital
  • Ministry of Science and Technology, Taiwan

Investigators

  • Principal Investigator: ZHUO HAO Liu, PhD, Department of Neurosurgery Chang Gung Memorial Hospital Chang Gung Medical College and University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT05534659
Other Study ID Numbers:
  • 202200775B0
First Posted:
Sep 9, 2022
Last Update Posted:
Sep 16, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Chang Gung Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2022